Werner Tschollar founded CanVirex AG together with Prof. Dr. Dr. Guy Ungerechts. He has over 25 years of experience in the pharmaceutical, biotech and financing industries.
Werner held executive positions at Bristol-Myers Squibb/Princeton, Schering Plough and Novartis, founded several biotech companies and was a co-founder of a large private equity fund in Geneva.
Werner has an MD degree and is board certified in clinical pharmacology, holds a degree in Pharmacy and has an MBA.